Yet, although CD8+ cell levels increased in the periphery of patients, to limit this antitumor activity, breast cancer probably induced the up-regulation of immune-suppressive molecules as PD1 and CD39 by both CD4+ and CD8+ lymphocytes and reduction in the levels of CD8+ cells in breast cancer tissue. This evidence concerns the gene CD8A and breast carcinoma.